Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt small index

Vaccination: later-stage trial registry

4 of 13 indexed Vaccination trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 4 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Vaccination: 13 US clinical trials tracked, 4 recruiting.

Vaccination is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Columbia University, running 3 of these trials.

Enrollment posture brief

Registry condition vaccination

OPEN 4 | RECR 31% | LATE 2 | EARLY 0 | RANK #1315 | SPON 3

Nearest open-share peer: Acute Decompensated Heart Failure (31% recruiting · 13 trials)

ACL Injury61.5%Acute Biphenotypic Leukemia46.2%Vaccination (this)31%Accidental Falls30.8%Actinic Keratoses23.1%
Open-enrollment share among volume-matched conditions near Vaccination

Vaccination lists 4 open slots (31% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vaccination on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vaccination is recruiting below its size-band peers.

    4 of 13 indexed trials (30.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Vaccination research.

    Columbia University accounts for 3 of 13 trials (23.1%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Vaccination enrolment sits around 1,100 participants.

    Median target enrolment is 1,100 among the 13 trials that report a genuine target (sentinel values excluded). 3 of those (23.1%) plan for fewer than 100 participants.

  4. Vaccination research is mostly interventional.

    12 interventional and 1 observational studies make up this index (92.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 42

Open and recent trials

13 total, page 1 of 1

RECRUITING NA 6,000 participants

Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults

Johns Hopkins Bloomberg School of Public Health

NCT06890403

RECRUITING 1,200 participants

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

National Institute of Allergy and Infectious Diseases (NIAID)

NCT05078905

RECRUITING NA 1,100 participants

"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake

Johns Hopkins Bloomberg School of Public Health

NCT06587243

RECRUITING NA 700 participants

ARISe at UMass Chan

University of Massachusetts, Worcester

NCT07236034

ACTIVE NOT RECRUITING NA 100,000 participants

Kaiser Colorado Flu Nudge

Kaiser Permanente

NCT07372950

COMPLETED NA 8,287 participants

Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients

Kaiser Permanente

NCT05096026

COMPLETED NA 2,586 participants

Text Message Reminder-Recalls For Early Childhood Vaccination

Columbia University

NCT01199666

COMPLETED NA 2,200 participants

P3+ Intervention Phase

Emory University

NCT02898688

COMPLETED NA 416 participants

Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions

Columbia University

NCT02231957

COMPLETED NA 222 participants

Influenza Vaccine Randomized Educational Trial: Adult

Columbia University

NCT02907645

COMPLETED NA 48 participants

The STOP-HPV Trial 2: Performance Feedback Intervention

University of California, Los Angeles

NCT03599570

COMPLETED Phase 4 22 participants

Special Access Program IMVAMUNE®

Bavarian Nordic

NCT03472014

COMPLETED Phase 4 20 participants

PFAS Exposure and Immune Response to Vaccination in Adults

Rutgers, The State University of New Jersey

NCT06588530

Phase Distribution

PhaseTrial count
Phase 4 2

Named interventions

Most-linked intervention names on Vaccination records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Personal Narrative Video Behavioral
2 trials
Informational Animation Video Behavioral
2 trials
National educational information Behavioral
1 trials
Local educational information Behavioral
1 trials
conventional text message reminders Other
1 trials
educational text message reminders Other
1 trials
Culturally Tailored PCP Outreach Behavioral
1 trials
Standard PCP Outreach Behavioral
1 trials

US sites by state

Facility locations filed on Vaccination trials. A trial with sites in several states counts in each.

New York 5 trials
Colorado 2 trials
California 2 trials
New Jersey 1 trials
Maryland 1 trials
Massachusetts 1 trials
Illinois 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Vaccination page

13 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vaccination condition card totals 13 registered trials; most-linked intervention Personal Narrative Video; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.